4/A: Charles River Laboratories Executive Knell Reports Share Transactions

Michael Knell, CSVP & Chief Accounting Officer of Charles River Laboratories, reports acquisition and disposal of company stock.

Summary

• Michael Knell, CSVP & Chief Accounting Officer of Charles River Laboratories International, Inc., filed an amendment to a Form 4 regarding changes in beneficial ownership.
• The earliest transaction date reported is January 29, 2024.
• Knell acquired 948 shares of common stock at $0 following the achievement of performance goals from performance share unit awards granted on May 28, 2021.
• Knell disposed of 313 shares of common stock at a price of $220.28.
• Following these transactions, Knell directly owns 10,575 shares of Charles River Laboratories common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The acquisition of shares due to performance goals is a positive sign, but the disposal of some shares introduces a slightly negative element. Overall, it appears to be a routine transaction.

Positives

• The acquisition of shares due to performance goals suggests confidence in the company's performance.

Negatives

• The disposal of 313 shares, while potentially for personal financial management, could be interpreted negatively by some investors.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's prospects.

Comparison to Industry Standards

• Executive compensation and stock ownership are typical components of corporate governance in publicly traded companies like Charles River Laboratories.
• Monitoring these transactions is a standard practice for investors to gauge alignment between management's interests and shareholder value.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholder sentiment, depending on how they interpret the executive's actions.

Key Dates